These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 30919348

  • 1. Measuring Recruitment of β-Arrestin to G Protein-Coupled Heterodimers Using Bioluminescence Resonance Energy Transfer.
    Fillion D, Devost D, Hébert TE.
    Methods Mol Biol; 2019; 1957():83-91. PubMed ID: 30919348
    [Abstract] [Full Text] [Related]

  • 2. Asymmetric Recruitment of β-Arrestin1/2 by the Angiotensin II Type I and Prostaglandin F2α Receptor Dimer.
    Fillion D, Devost D, Sleno R, Inoue A, Hébert TE.
    Front Endocrinol (Lausanne); 2019; 10():162. PubMed ID: 30936850
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Functional selectivity profiling of the angiotensin II type 1 receptor using pathway-wide BRET signaling sensors.
    Namkung Y, LeGouill C, Kumar S, Cao Y, Teixeira LB, Lukasheva V, Giubilaro J, Simões SC, Longpré JM, Devost D, Hébert TE, Piñeyro G, Leduc R, Costa-Neto CM, Bouvier M, Laporte SA.
    Sci Signal; 2018 Dec 04; 11(559):. PubMed ID: 30514808
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Conformational biosensors reveal allosteric interactions between heterodimeric AT1 angiotensin and prostaglandin F2α receptors.
    Sleno R, Devost D, Pétrin D, Zhang A, Bourque K, Shinjo Y, Aoki J, Inoue A, Hébert TE.
    J Biol Chem; 2017 Jul 21; 292(29):12139-12152. PubMed ID: 28584054
    [Abstract] [Full Text] [Related]

  • 8. Quantifying biased signaling in GPCRs using BRET-based biosensors.
    Namkung Y, Radresa O, Armando S, Devost D, Beautrait A, Le Gouill C, Laporte SA.
    Methods; 2016 Jan 01; 92():5-10. PubMed ID: 25890247
    [Abstract] [Full Text] [Related]

  • 9. Bioluminescence Resonance Energy Transfer (BRET) to Detect the Interactions Between Kappa Opioid Receptor and Nonvisual Arrestins.
    Bedini A.
    Methods Mol Biol; 2021 Jan 01; 2201():45-58. PubMed ID: 32975788
    [Abstract] [Full Text] [Related]

  • 10. Monitoring G protein-coupled receptor and β-arrestin trafficking in live cells using enhanced bystander BRET.
    Namkung Y, Le Gouill C, Lukashova V, Kobayashi H, Hogue M, Khoury E, Song M, Bouvier M, Laporte SA.
    Nat Commun; 2016 Jul 11; 7():12178. PubMed ID: 27397672
    [Abstract] [Full Text] [Related]

  • 11. Heterologous phosphorylation-induced formation of a stability lock permits regulation of inactive receptors by β-arrestins.
    Tóth AD, Prokop S, Gyombolai P, Várnai P, Balla A, Gurevich VV, Hunyady L, Turu G.
    J Biol Chem; 2018 Jan 19; 293(3):876-892. PubMed ID: 29146594
    [Abstract] [Full Text] [Related]

  • 12. Angiotensin type 1A receptor regulates β-arrestin binding of the β2-adrenergic receptor via heterodimerization.
    Tóth AD, Gyombolai P, Szalai B, Várnai P, Turu G, Hunyady L.
    Mol Cell Endocrinol; 2017 Feb 15; 442():113-124. PubMed ID: 27908837
    [Abstract] [Full Text] [Related]

  • 13. BRET approaches to characterize dopamine and TAAR1 receptor pharmacology and signaling.
    Espinoza S, Masri B, Salahpour A, Gainetdinov RR.
    Methods Mol Biol; 2013 Feb 15; 964():107-22. PubMed ID: 23296781
    [Abstract] [Full Text] [Related]

  • 14. Differential β-arrestin-dependent conformational signaling and cellular responses revealed by angiotensin analogs.
    Zimmerman B, Beautrait A, Aguila B, Charles R, Escher E, Claing A, Bouvier M, Laporte SA.
    Sci Signal; 2012 Apr 24; 5(221):ra33. PubMed ID: 22534132
    [Abstract] [Full Text] [Related]

  • 15. c-Src regulates clathrin adapter protein 2 interaction with beta-arrestin and the angiotensin II type 1 receptor during clathrin- mediated internalization.
    Fessart D, Simaan M, Laporte SA.
    Mol Endocrinol; 2005 Feb 24; 19(2):491-503. PubMed ID: 15498833
    [Abstract] [Full Text] [Related]

  • 16. Loss of biased signaling at a G protein-coupled receptor in overexpressed systems.
    Li A, Liu S, Huang R, Ahn S, Lefkowitz RJ.
    PLoS One; 2023 Feb 24; 18(3):e0283477. PubMed ID: 36961836
    [Abstract] [Full Text] [Related]

  • 17. Mechanoactivation of the angiotensin II type 1 receptor induces β-arrestin-biased signaling through Gαi coupling.
    Wang J, Hanada K, Gareri C, Rockman HA.
    J Cell Biochem; 2018 Apr 24; 119(4):3586-3597. PubMed ID: 29231251
    [Abstract] [Full Text] [Related]

  • 18. The apelin receptor inhibits the angiotensin II type 1 receptor via allosteric trans-inhibition.
    Siddiquee K, Hampton J, McAnally D, May L, Smith L.
    Br J Pharmacol; 2013 Mar 24; 168(5):1104-17. PubMed ID: 22935142
    [Abstract] [Full Text] [Related]

  • 19. BRET-based assay to monitor EGFR transactivation by the AT1R reveals Gq/11 protein-independent activation and AT1R-EGFR complexes.
    O'Brien SL, Johnstone EKM, Devost D, Conroy J, Reichelt ME, Purdue BW, Ayoub MA, Kawai T, Inoue A, Eguchi S, Hébert TE, Pfleger KDG, Thomas WG.
    Biochem Pharmacol; 2018 Dec 24; 158():232-242. PubMed ID: 30347205
    [Abstract] [Full Text] [Related]

  • 20. Noncanonical scaffolding of Gαi and β-arrestin by G protein-coupled receptors.
    Smith JS, Pack TF, Inoue A, Lee C, Zheng K, Choi I, Eiger DS, Warman A, Xiong X, Ma Z, Viswanathan G, Levitan IM, Rochelle LK, Staus DP, Snyder JC, Kahsai AW, Caron MG, Rajagopal S.
    Science; 2021 Mar 12; 371(6534):. PubMed ID: 33479120
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.